← Leaderboards
Herbert Kim Lyerly
Duke University
$345,072
Attributed
$345,072
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$345,072 · 2
By mechanism
P01$345,072 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Herbert Kim Lyerly$48,598,090
- Victoria L. Seewaldt$17,302,500
- Mikhail Nikiforov$14,564,827
- Eli Gilboa$17,521,988
- Hui-Kuan Lin$13,610,941
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsNeoplasm /Cancer ImmunotherapyClinical ResearchClinical Trial Phase IColorectal NeoplasmsCytotoxic T LymphocyteData ManagementHelper T LymphocyteHuman SubjectHuman Therapy EvaluationImmune Tolerance /UnresponsivenessInformation SystemsLiver NeoplasmsMetastasisNeoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer VaccinePublicationsStatistics /BiometryTumor AntigensBiomedical FacilityVaccine DevelopmentCarcinoembryonal Antigen
Grant awards (6)
CLINICAL TRIALS OF RNA TRANSFECTED DENDRITIC CELL IMMUNOTHERAPY$86,268
P01 · FY2002 · CA
CORE--BIOSTATISTICS$86,268
P01 · FY2002 · CA
CLINICAL TRIALS OF RNA TRANSFECTED DENDRITIC CELL IMMUNOTHERAPY$86,268
P01 · FY2001 · CA
CORE--BIOSTATISTICS$86,268
P01 · FY2001 · CA
CLINICAL TRIALS OF RNA TRANSFECTED DENDRITIC CELL IMMUNOTHERAPY$0
P01 · FY2000 · CA
CORE--BIOSTATISTICS$0
P01 · FY2000 · CA